187 related articles for article (PubMed ID: 30938471)
1. Different pharmaceutical preparations of Δ
Rohleder C; Pahlisch F; Graf R; Endepols H; Leweke FM
Addict Biol; 2020 May; 25(3):e12745. PubMed ID: 30938471
[TBL] [Abstract][Full Text] [Related]
2. Adolescent exposure to Δ9-tetrahydrocannabinol delays acquisition of paired-associates learning in adulthood.
Abela AR; Rahbarnia A; Wood S; Lê AD; Fletcher PJ
Psychopharmacology (Berl); 2019 Jun; 236(6):1875-1886. PubMed ID: 30694374
[TBL] [Abstract][Full Text] [Related]
3. The effect of Delta9-tetrahydrocannabinol on sensorimotor gating in socially isolated rats.
Malone DT; Taylor DA
Behav Brain Res; 2006 Jan; 166(1):101-9. PubMed ID: 16143410
[TBL] [Abstract][Full Text] [Related]
4. HIV Transgenic Rats Demonstrate Impaired Sensorimotor Gating But Are Insensitive to Cannabinoid (Δ9-Tetrahydrocannabinol)-Induced Deficits.
Roberts BZ; Minassian A; Halberstadt AL; He YV; Chatha M; Geyer MA; Grant I; Young JW
Int J Neuropsychopharmacol; 2021 Nov; 24(11):894-906. PubMed ID: 34338765
[TBL] [Abstract][Full Text] [Related]
5. Reduced type III neuregulin 1 expression does not modulate the behavioural sensitivity of mice to acute Δ
Lloyd D; Talmage D; Shannon Weickert C; Karl T
Pharmacol Biochem Behav; 2018 Jul; 170():64-70. PubMed ID: 29750976
[TBL] [Abstract][Full Text] [Related]
6. Developmentally vitamin D-deficient rats show enhanced prepulse inhibition after acute Δ9-tetrahydrocannabinol.
Burne TH; Alexander S; Turner KM; Eyles DW; McGrath JJ
Behav Pharmacol; 2014 Jun; 25(3):236-44. PubMed ID: 24776491
[TBL] [Abstract][Full Text] [Related]
7. Chronic nicotine exposure attenuates the effects of Δ
Manwell LA; Miladinovic T; Raaphorst E; Rana S; Malecki S; Mallet PE
Brain Behav; 2019 Nov; 9(11):e01375. PubMed ID: 31583843
[TBL] [Abstract][Full Text] [Related]
8. Repeated but not acute treatment with ∆⁹-tetrahydrocannabinol disrupts prepulse inhibition of the acoustic startle: reversal by the dopamine D₂/₃ receptor antagonist haloperidol.
Tournier BB; Ginovart N
Eur Neuropsychopharmacol; 2014 Aug; 24(8):1415-23. PubMed ID: 24846537
[TBL] [Abstract][Full Text] [Related]
9. Adolescent THC Treatment Does Not Potentiate the Behavioral Effects in Adulthood of Maternal Immune Activation.
Stollenwerk TM; Hillard CJ
Cells; 2021 Dec; 10(12):. PubMed ID: 34944011
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic and behavioural profile of THC, CBD, and THC+CBD combination after pulmonary, oral, and subcutaneous administration in rats and confirmation of conversion in vivo of CBD to THC.
Hložek T; Uttl L; Kadeřábek L; Balíková M; Lhotková E; Horsley RR; Nováková P; Šíchová K; Štefková K; Tylš F; Kuchař M; Páleníček T
Eur Neuropsychopharmacol; 2017 Dec; 27(12):1223-1237. PubMed ID: 29129557
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotic potential of the type 1 cannabinoid receptor positive allosteric modulator GAT211: preclinical in vitro and in vivo studies.
McElroy DL; Roebuck AJ; Scott GA; Greba Q; Garai S; Denovan-Wright EM; Thakur GA; Laprairie RB; Howland JG
Psychopharmacology (Berl); 2021 Apr; 238(4):1087-1098. PubMed ID: 33442771
[TBL] [Abstract][Full Text] [Related]
12. Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of Delta9-tetrahydrocannabinol.
Boucher AA; Arnold JC; Duffy L; Schofield PR; Micheau J; Karl T
Psychopharmacology (Berl); 2007 Jun; 192(3):325-36. PubMed ID: 17333138
[TBL] [Abstract][Full Text] [Related]
13. Sex and age specific effects of delta-9-tetrahydrocannabinol during the periadolescent period in the rat: The unique susceptibility of the prepubescent animal.
Silva L; Black R; Michaelides M; Hurd YL; Dow-Edwards D
Neurotoxicol Teratol; 2016; 58():88-100. PubMed ID: 26898326
[TBL] [Abstract][Full Text] [Related]
14. Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor activity.
Katsidoni V; Kastellakis A; Panagis G
Int J Neuropsychopharmacol; 2013 Nov; 16(10):2273-84. PubMed ID: 23830148
[TBL] [Abstract][Full Text] [Related]
15. THC inhibits the expression of ethanol-induced locomotor sensitization in mice.
Filev R; Engelke DS; Da Silveira DX; Mello LE; Santos-Junior JG
Alcohol; 2017 Dec; 65():31-35. PubMed ID: 29084627
[TBL] [Abstract][Full Text] [Related]
16. A vapourized Δ(9)-tetrahydrocannabinol (Δ(9)-THC) delivery system part II: comparison of behavioural effects of pulmonary versus parenteral cannabinoid exposure in rodents.
Manwell LA; Ford B; Matthews BA; Heipel H; Mallet PE
J Pharmacol Toxicol Methods; 2014; 70(1):112-9. PubMed ID: 24956154
[TBL] [Abstract][Full Text] [Related]
17. A vapourized Δ(9)-tetrahydrocannabinol (Δ(9)-THC) delivery system part I: development and validation of a pulmonary cannabinoid route of exposure for experimental pharmacology studies in rodents.
Manwell LA; Charchoglyan A; Brewer D; Matthews BA; Heipel H; Mallet PE
J Pharmacol Toxicol Methods; 2014; 70(1):120-7. PubMed ID: 24973534
[TBL] [Abstract][Full Text] [Related]
18. Highway to hell or magic smoke? The dose-dependence of Δ
Kubilius RA; Kaplick PM; Wotjak CT
Learn Mem; 2018 Sep; 25(9):446-454. PubMed ID: 30115766
[TBL] [Abstract][Full Text] [Related]
19. Is 2-Hydroxypropyl-β-cyclodextrin a Suitable Carrier for Central Administration of Δ
Agabio R; Sanna F; Lobina C; Monduzzi M; Nairi V; Cugia F; Mameli S; Pisanu GM; Gessa GL; Melis MR
Drug Dev Res; 2017 Dec; 78(8):411-419. PubMed ID: 28921601
[TBL] [Abstract][Full Text] [Related]
20. A follow-up study: acute behavioural effects of Delta(9)-THC in female heterozygous neuregulin 1 transmembrane domain mutant mice.
Long LE; Chesworth R; Arnold JC; Karl T
Psychopharmacology (Berl); 2010 Aug; 211(3):277-89. PubMed ID: 20571781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
